{"gene":"VCAN","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":1986,"finding":"PG-M (versican) binds directly to fibronectin and type I collagen, but not to laminin or type IV collagen, and mediates binding of hyaluronate to cellular fibronectin; the hyaluronate-binding activity in fibronectin preparations was immunoprecipitable with anti-PG-M antibody, demonstrating that PG-M is responsible for this activity.","method":"Immunoprecipitation, affinity purification, CsCl isopycnic centrifugation, binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal immunoprecipitation plus direct binding assays with multiple ECM ligands tested, replicated across different cell sources","pmids":["3759976"],"is_preprint":false},{"year":1986,"finding":"PG-M (versican) is synthesized as the predominant large chondroitin sulfate proteoglycan in chick embryo limb buds before chondrogenesis, with a core protein of ~550 kDa, and its distribution closely follows mesenchymal cell condensation, suggesting a role in the condensation process.","method":"Metabolic labeling with [35S]sulfate, CsCl isopycnic centrifugation, SDS-PAGE, tryptic peptide mapping, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical and histological methods in single lab; functional role inferred from localization","pmids":["3759975"],"is_preprint":false},{"year":1993,"finding":"The PG-M/versican core protein contains an N-terminal hyaluronan-binding domain and C-terminal EGF-like domains, a C-type lectin-like domain, and a complement regulatory protein (CRP)-like domain, as deduced from cDNA sequence analysis; multiple alternatively spliced isoforms (V0, V1, V2, V3) are generated by alternative usage of two chondroitin sulfate attachment domains (CS-α and CS-β).","method":"cDNA cloning and sequencing, alternative splicing analysis, homology analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — primary structural determination by cDNA sequencing confirmed in multiple subsequent studies","pmids":["8314802"],"is_preprint":false},{"year":1994,"finding":"The C-terminal (G3) domain of PG-M binds D-mannose, D-galactose, L-fucose, and N-acetyl-D-glucosamine in a calcium-dependent manner (C-type lectin activity), and also binds heparin/heparan sulfate; both activities require the intact CRP-like domain, as removal of this domain abolishes both C-type lectin and heparin binding activities.","method":"Expression of GST-fusion protein, affinity chromatography, truncation mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding assays with recombinant protein and domain deletion mutagenesis in single lab with clear mechanistic readout","pmids":["7961677"],"is_preprint":false},{"year":1994,"finding":"PG-M/versican acts as an anti-adhesive molecule; it is excluded from focal contacts of fibroblasts and from podosomes of osteosarcoma cells, and antisense-mediated suppression of PG-M/versican biosynthesis suppresses the malignant podosome-type adhesion phenotype of human osteosarcoma cells.","method":"Antisense inhibition, immunofluorescence localization, cell adhesion assays","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — antisense loss-of-function with specific morphological phenotype readout, supported by localization data, single lab","pmids":["7531202"],"is_preprint":false},{"year":1995,"finding":"Multiple PG-M isoforms (V0 containing both CS-α and CS-β domains, V1 with CS-β only, V2 with CS-α only, and V3 with neither) are generated from a single genomic locus by alternative splicing of two large exons (exon VII encoding CS-α, 2880 bp; exon VIII encoding CS-β, 5229 bp); the V3 isoform lacks any chondroitin sulfate attachment region.","method":"Genomic DNA analysis, Northern hybridization, cDNA sequencing, PCR, Southern blotting","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — primary genomic structural determination confirmed by multiple methods; replicated across species","pmids":["7730339","7876137"],"is_preprint":false},{"year":1998,"finding":"Normal expression of the Cspg2 (versican) gene is required for formation of endocardial cushion swellings and the embryonic heart segments that give rise to the right ventricle and conus/truncus; hdf mice carrying a transgene insertional mutation disrupting Cspg2 die in utero by E10.5 and completely lack endocardial cushions and right cardiac chamber.","method":"Transgene insertional mutagenesis, chromosome mapping, immunohistochemistry, expression analysis (exon boundary PCR), genomic cloning","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — four independent lines of evidence (mapping, IHC, expression analysis, genomic sequencing) establishing loss-of-function cardiac phenotype","pmids":["9758703"],"is_preprint":false},{"year":2000,"finding":"PG-M/versicans V0 and V1 isoforms are expressed along neural crest migratory pathways and promote directed (haptotactic) neural crest cell migration via HNK-1 antigen-bearing cell surface components; orthotopic implantation of PG-M/versican attracts migrating neural crest cells, whereas aggrecan retains them. Inhibitory effect of aggrecan on neural crest migration requires intact G1 domain-mediated association with cell-surface hyaluronan.","method":"In situ hybridization, immunohistochemistry, TEM/rotary shadowing, orthotopic microsphere implantation, 3D collagen migration assay, chondroitinase treatment","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vitro and in vivo methods establishing mechanistic divergence between versican and aggrecan on neural crest migration","pmids":["10851128"],"is_preprint":false},{"year":2000,"finding":"PG-M/versican binds midkine (a heparin-binding growth factor) with Kd of 1.0 nM through the chondroitin sulfate chains; binding requires polysulfated regions and is abolished by chondroitinase ABC digestion; pleiotrophin binds similarly.","method":"Affinity purification, in-gel trypsin digestion/peptide sequencing, binding assay, chondroitinase digestion, competition with heparin/CS variants","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay with Kd determination and enzyme digestion to map binding domain, single lab","pmids":["10866805"],"is_preprint":false},{"year":2002,"finding":"The C-terminal G3 domain of PG-M/versican binds β1-integrin in a calcium- and manganese-dependent manner (not via RGD motif); this interaction activates focal adhesion kinase, enhances integrin expression, promotes cell adhesion, and confers resistance to free radical-induced apoptosis.","method":"Pull-down assay, immunoprecipitation, cell-surface binding assay, native gel electrophoresis, FAK phosphorylation assay, apoptosis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal binding assays plus functional downstream signaling and apoptosis readouts in single lab","pmids":["11805102"],"is_preprint":false},{"year":2003,"finding":"Versican/PG-M G1 domain binds both hyaluronan (HA) and link protein (LP); the B-B' subdomain of the G1 domain is sufficient for both HA and LP binding; the A subdomain enhances HA binding but has negligible effect on LP binding. A structural model of B-B' identifies deletion/insertion features critical for stable structure and HA binding.","method":"BIAcore surface plasmon resonance, recombinant subdomain expression, overlay sensorgrams, molecular modeling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — SPR binding kinetics with recombinant domain constructs and molecular modeling, single lab but rigorous","pmids":["12888576"],"is_preprint":false},{"year":2003,"finding":"The G3 domains of PG-M/versican and aggrecan form intermolecular disulfide bonds involving all subdomains and all 10 cysteine residues; disruption of these disulfide bonds with reducing agents disrupts chondrocyte-matrix interaction, alters ECM structure, and reduces G3 domain-mediated cell adhesion.","method":"Recombinant protein expression, non-reducing SDS-PAGE, reducing agent treatment, chondrocyte-matrix interaction assay, cell adhesion assay","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution with disulfide bond disruption and functional readouts, single lab","pmids":["12846582"],"is_preprint":false},{"year":2004,"finding":"Versican G3 domain directly binds fibronectin and forms a trimeric complex with fibronectin and VEGF; this complex enhances endothelial cell adhesion, proliferation, and migration, and G3-expressing tumor cells show increased fibronectin and VEGF expression and enhanced angiogenesis in vivo.","method":"G3 construct expression in U87 cells, soft agarose colony assay, nude mouse tumor model, endothelial cell adhesion/proliferation/migration assays, co-immunoprecipitation of G3-fibronectin-VEGF complex","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal in vitro and in vivo methods with direct complex identification, single lab","pmids":["14766798"],"is_preprint":false},{"year":2004,"finding":"Versican G3 domain lacking EGF-like motifs (G3ΔEGF) acts as a dominant-negative, impairs versican secretion, enhances tumor cell adhesion, and prevents anchorage-independent growth. This mutant sustains FAK phosphorylation and integrin-EGFR association after serum withdrawal but reduces EGFR phosphorylation, demonstrating that the versican G3 domain modulates EGFR-integrin crosstalk to promote tumorigenesis.","method":"Dominant-negative G3ΔEGF transfection, FAK phosphorylation assay, co-immunoprecipitation of integrin-EGFR, soft agar growth assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative approach with signaling readouts and functional assays, single lab","pmids":["15126624"],"is_preprint":false},{"year":2004,"finding":"PG-M/versican G3 domain binds P-selectin glycoprotein ligand-1 (PSGL-1); versican G3 multimers bridge PSGL-1-expressing leukocytes to induce leukocyte aggregation; endogenous G3-containing versican fragments in human plasma contribute to leukocyte aggregation, and removal of these fragments reduces the effect.","method":"Transfection, cell aggregation assay, PSGL-1 binding assays, human plasma depletion experiments, mouse model","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vitro and in vivo systems confirming binding and functional consequence, single lab","pmids":["15522894"],"is_preprint":false},{"year":2005,"finding":"Versican/PG-M is required for mesenchymal condensation and chondrogenesis; chondrogenic stimuli upregulate V0 and V1 isoforms (containing more CS chains); antisense suppression of versican reduces chondrogenesis; chondroitinase ABC treatment or β-xyloside treatment (inhibiting CS chain addition to core proteins) suppresses chondrogenesis; forced expression of V3 (no CS chains) disrupts native versican organization and inhibits chondrogenesis.","method":"Antisense stable clones, chondroitinase ABC treatment, β-xyloside treatment, V3 overexpression, aggrecan deposition assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple loss-of-function approaches (antisense, enzyme digestion, chain synthesis inhibition, dominant-negative V3) all converging on same phenotype","pmids":["16257955"],"is_preprint":false},{"year":2006,"finding":"Versican/PG-M is present in articular cartilage as a proteoglycan aggregate with both link protein and hyaluronan (distinct from the aggrecan aggregate); its CS chains are predominantly nonsulfated (71%) and 4-sulfated (28%). Link protein overexpression enhances versican matrix deposition and prevents subsequent aggrecan deposition.","method":"Immunostaining, biochemical analysis of aggrecan-null (cmd/cmd) cartilage, chondroitinase ABC digestion/disaccharide analysis, link protein overexpression in N1511 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical characterization with genetic controls (aggrecan-null mice) and overexpression experiment, single lab","pmids":["16648631"],"is_preprint":false},{"year":2006,"finding":"Intronic mutations in CSPG2/VCAN at the splice acceptor site of intron 7 cause Wagner disease and erosive vitreoretinopathy by shifting the balance of splice variants: a >38-fold increase in V2 and >12-fold increase in V3 isoforms is consistently observed in patient tissues, representing a disease mechanism based on isoform imbalance rather than simple loss of function.","method":"Genetic linkage analysis, Sanger sequencing of CSPG2, RT-PCR of splice variants, quantitative RT-PCR (QPCR) in patient-derived tissues","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative splice variant analysis across multiple families showing consistent isoform imbalance as pathogenic mechanism; replicated in multiple families and subsequent studies","pmids":["16877430"],"is_preprint":false},{"year":2007,"finding":"Hyaluronan-versican aggregates (but not native hyaluronan alone) promote stromal cell recruitment and endothelial cell infiltration in Matrigel plug angiogenesis assays, indicating that the versican-HA complex is required for the pro-angiogenic activity.","method":"Matrigel plug assay, comparison of hyaluronan-versican aggregates vs. native HA, histological analysis of stromal/endothelial cell infiltration","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo comparison with purified complexes, single lab, clear mechanistic readout","pmids":["17322391"],"is_preprint":false},{"year":2009,"finding":"Versican/PG-M is essential for assembling hyaluronan into extracellular matrix; knock-in mice (Cspg2Δ3/Δ3) lacking the A subdomain of the G1 domain show decreased versican and HA deposition, increased free HA fragments that interact with CD44, elevated ERK1/2 phosphorylation, and premature cellular senescence. Wild-type fibroblast treatment with hyaluronidase or exogenous HA enhances ERK1/2 phosphorylation via CD44; anti-CD44 antibody blocking inhibits this phosphorylation.","method":"Knock-in mouse model, ECM network immunofluorescence, anti-CD44 blocking antibody, ERK1/2 phosphorylation assay, senescence marker analysis (p53, p21, p16), exogenous HA/hyaluronidase treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic model with multiple orthogonal mechanistic readouts linking versican's HA-organizing function to CD44-ERK signaling and senescence","pmids":["19164294"],"is_preprint":false},{"year":2012,"finding":"Versican/PG-M is required for ventricular septal formation subsequent to AV cushion development; Vcan knockout mice (Vcan Δ3/Δ3) show smaller AV cushions with narrowed ECM/cardiac jelly space, condensed HA without versican, and ventricular septal defects; ex vivo explant culture shows impaired cell migration in these regions. The A subdomain of the G1 domain is essential for proper proteoglycan aggregate formation and interventricular septal morphogenesis.","method":"Conditional Vcan knockout mouse, immunostaining, Ki67 proliferation assay, ex vivo collagen gel explant migration assay","journal":"Glycobiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout model with specific histological and functional mechanistic readouts, ex vivo validation","pmids":["22692047"],"is_preprint":false},{"year":2012,"finding":"Novel splice acceptor and donor-site mutations in VCAN (introns 7 and 8) cause Wagner syndrome through a pathogenic mechanism of increased transcript variants lacking exons 7 and/or 8, with reduction in glycosaminoglycan modifications; the magnitude of the isoform shift varies between tissues and mutations.","method":"Family-based genetic linkage, Sanger sequencing, qRT-PCR of isoforms in patient-derived venous blood and skin fibroblasts","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — qRT-PCR isoform analysis in patient-derived tissues across three independent families, mechanistic model confirmed at RNA level","pmids":["22739342"],"is_preprint":false},{"year":2014,"finding":"Imbalanced expression of Vcan splice forms (deletion of exon 7 prevents V0 and V2 expression) results in ventricular septal defects, smaller valve cushions with diminished myocardialization, and altered outflow tracts; proteomic profiling of Vcan(tm1Zim) hearts identifies compensatory changes in cytoskeletal and muscle contraction proteins.","method":"Exon 7 deletion mouse model (Vcan(tm1Zim)), histology, large-scale differential protein expression profiling (proteomics)","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic model with proteomic profiling; consistent with other Vcan loss-of-function cardiac studies but single lab","pmids":["24586547"],"is_preprint":false},{"year":2019,"finding":"A VCAN splice site mutation (c.4004-2A>G) eliminates an MMP cleavage site in the GAGβ chain (VCAN p.1335-1347 deletion), validated by FRET-based proteolysis assays; loss of this MMP cleavage site alters versican structure and results in abnormal vitreous ECM modeling, causing vitreoretinal degeneration.","method":"Sanger sequencing, protein structural modeling, FRET-based in vitro proteolysis assay, proteomic network analysis","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — FRET proteolysis assay directly demonstrates MMP cleavage site loss; structural modeling supports mechanism; single lab","pmids":["30657523"],"is_preprint":false},{"year":2018,"finding":"Snail induces co-expression of PAPSS2 (rate-limiting enzyme in sulfation) and VCAN in breast cancer cells; depletion of VCAN dampens the cell migration activity induced by Snail or PAPSS2 in MCF 10A cells, establishing VCAN as a downstream effector in the Snail/PAPSS2 sulfation axis driving EMT and metastasis.","method":"shRNA knockdown, overexpression, cell migration assay, in vivo lung metastasis model (nude mice), PAPSS inhibitor (sodium chlorate) treatment","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic and pharmacological loss-of-function approaches with in vitro and in vivo metastasis readouts, single lab","pmids":["29955124"],"is_preprint":false},{"year":2002,"finding":"Vascular PG-M/versican isoforms V1 and V2 promote platelet adhesion in a shear rate-dependent manner primarily through their dermatan sulfate chains; versicans incorporated into fibrillar collagen strongly promote platelet aggregation at both low and high shear rates; a 120-140 kDa polypeptide complex on the platelet surface serves as the versican-binding membrane ligand.","method":"Real-time platelet perfusion assay, glycosaminoglycan lyase digestion, competition with purified GAGs, affinity chromatography on DS-Sepharose, solid-phase binding assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (perfusion, enzyme digestion, affinity chromatography) establishing mechanism of platelet-versican interaction, single lab","pmids":["12468455"],"is_preprint":false},{"year":2023,"finding":"TGF-β1 derived from stromal fibroblasts upregulates FAP in fibroblasts, which in turn upregulates VCAN as a downstream molecule; VCAN plays an essential role in TGF-β1/FAP axis-induced EMT in bladder cancer cells potentially through PI3K/AKT1 signaling pathway.","method":"Primary CAF isolation, conditioned medium co-culture system, cytokine antibody array, gene set enrichment analysis, shRNA knockdown, cell migration/invasion assays","journal":"Journal of translational medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — functional assays in co-culture system but PI3K/AKT1 mechanism only proposed, not directly validated for VCAN specifically; single lab","pmids":["37461061"],"is_preprint":false},{"year":2024,"finding":"ADAMTS1 proteolytically cleaves versican V1 (VCAN V1), generating fragments that activate EGFR transactivation, which drives anoikis resistance and invasion in renal cell carcinoma; ADAMTS1 also forms a complex with p53 to modulate EGFR signaling. VCAN knockdown reverses ADAMTS1-induced pro-metastatic characteristics in vivo.","method":"RTK array screening, IP assays, luciferase reporter assays, western blotting, RT-qPCR, anoikis resistance assays, invasion assays, zebrafish xenotransplantation","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (IP, luciferase, functional assays, in vivo model) establishing ADAMTS1-VCAN-EGFR axis, single lab","pmids":["39333870"],"is_preprint":false},{"year":2025,"finding":"STAT5 acts as a transcription factor that promotes VCAN expression upon bleomycin induction; elevated VCAN promotes fibroblast activation through the PI3K signaling pathway; fibroblast-specific VCAN knockout significantly reduces lung fibroblast activation and lung fibrosis in mice.","method":"Fibroblast-specific conditional VCAN knockout mice, Western blot, immunohistochemistry, immunofluorescence, chromatin immunoprecipitation (CHIP), luciferase reporter gene analysis, PI3K inhibitor treatment, bleomycin/radiation fibrosis models","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse with mechanistic validation of STAT5 transcriptional regulation and PI3K pathway downstream, multiple methods in single lab","pmids":["40617369"],"is_preprint":false},{"year":2025,"finding":"VCAN interacts with CD44 receptors on tumor-associated macrophages via paracrine secretion, promoting M2 macrophage polarization and VEGF-C secretion to facilitate lymphangiogenesis; VCAN also binds CD44 on gastric cancer cells via autocrine secretion, activating the Hippo pathway and upregulating SP1 to promote MIR181A2HG transcription, establishing a feedback loop.","method":"Co-IP, RNA-pulldown, luciferase reporter assay, CHIP, immunofluorescence, ELISA, in vitro and in vivo functional studies","journal":"Cancer medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — CD44 interaction and downstream pathway supported by Co-IP and reporter assays, but complex multi-step mechanism established in single study with limited orthogonal validation of each step","pmids":["39823128"],"is_preprint":false},{"year":2024,"finding":"VCAN is identified as a transcriptional target of ERK5 in soft tissue sarcoma; VCAN silencing phenocopies ERK5 silencing (impaired migration, adhesion, proliferation, tumorigenesis) and VCAN overexpression rescues ERK5 silencing phenotypes, confirming VCAN as an essential downstream mediator of ERK5-driven oncogenesis.","method":"shRNA silencing, overexpression, pharmacological ERK5 inhibition, migration/adhesion/proliferation/tumorigenesis assays, murine sarcoma model, transcriptomic profiling, human biopsy analysis (mRNA/protein)","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via silencing and rescue experiments with multiple functional readouts, murine and human validation, single lab","pmids":["41800245"],"is_preprint":false},{"year":2024,"finding":"Versican promotes glioma cell proliferation and migration through the PI3K/Akt/AP-1 signaling pathway; PI3K/Akt pathway inhibition blocks VCAN-mediated glioma progression.","method":"VCAN overexpression in glioma cell lines, PI3K/Akt inhibitor treatment, functional proliferation and migration assays, transcriptomic analysis","journal":"Frontiers in neuroscience","confidence":"Low","confidence_rationale":"Tier 3 / Weak — overexpression with pathway inhibitor, single lab, limited mechanistic depth for pathway placement","pmids":["39554845"],"is_preprint":false},{"year":2025,"finding":"Promoter hypomethylation (mediated by reduced DNA methyltransferase activity under hypoxia) upregulates versican expression; versican promotes endothelial-to-mesenchymal transition (EndMT) by targeting the transcription factor Twist1, driving pulmonary hypertension progression; endothelium-specific versican knockdown reverses HPH and prevents EndMT.","method":"Co-immunoprecipitation (versican-Twist1 interaction), Western blot, immunohistochemistry, immunofluorescence, methylation-specific PCR, endothelium-specific knockdown in mouse HPH model, hemodynamic measurements","journal":"Journal of the American Heart Association","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for direct protein interaction plus conditional KO model and epigenetic mechanism, single lab","pmids":["39578365"],"is_preprint":false}],"current_model":"VCAN/versican (CSPG2/PG-M) is a large modular chondroitin sulfate proteoglycan whose N-terminal G1 domain binds hyaluronan (via the B-B' subdomains) and link protein to form proteoglycan aggregates in the ECM, while its C-terminal G3 domain mediates calcium-dependent lectin-type binding to sugars and heparin, binds fibronectin, VEGF, β1-integrin (non-RGD), and PSGL-1, and forms stabilizing intermolecular disulfide bonds; alternatively spliced isoforms (V0–V3) differing in chondroitin sulfate attachment domain content are expressed in a tissue- and developmental stage-specific manner, with the V0/V1 CS-rich isoforms required for mesenchymal condensation, cardiac cushion/septal morphogenesis, and neural crest migration, and splicing imbalance (excess V2/V3) caused by intronic VCAN mutations—disrupting an MMP cleavage site in the GAGβ domain—underlying Wagner vitreoretinopathy; in cancer, VCAN acts downstream of Snail/PAPSS2 sulfation, TGF-β1/FAP, ERK5, and ADAMTS1 proteolysis (which releases versican fragments that transactivate EGFR), and promotes cell migration, EMT, and anoikis resistance, while versican-assembled HA matrices regulate CD44-ERK1/2 signaling and cellular senescence, and STAT5 drives VCAN transcription to activate PI3K-dependent fibroblast activation in pulmonary fibrosis."},"narrative":{"mechanistic_narrative":"VCAN (versican/PG-M/CSPG2) is a large modular chondroitin sulfate proteoglycan that organizes the extracellular matrix and transduces matrix signals controlling cell adhesion, migration, condensation, and morphogenesis [PMID:3759975, PMID:8314802]. Its N-terminal G1 domain binds hyaluronan and link protein to assemble proteoglycan aggregates, with the B-B' subdomain sufficient for both interactions and the A subdomain enhancing hyaluronan binding and required for stable aggregate formation [PMID:12888576, PMID:16648631]; this hyaluronan-organizing function is essential for ECM assembly, and its loss releases free HA fragments that engage CD44, elevate ERK1/2 phosphorylation, and trigger premature senescence [PMID:19164294]. The C-terminal G3 domain provides calcium-dependent C-type lectin and heparin-binding activities dependent on the CRP-like module, mediates intermolecular disulfide bonding, and engages fibronectin, VEGF, non-RGD β1-integrin, and PSGL-1 to activate FAK, support adhesion, confer apoptosis resistance, promote angiogenesis, and bridge leukocytes [PMID:7961677, PMID:12846582, PMID:11805102, PMID:14766798, PMID:15522894]. The core protein is expressed as alternatively spliced isoforms V0–V3 differing in CS-α and CS-β attachment domain content [PMID:8314802, PMID:7730339, PMID:7876137], and the CS-rich V0/V1 isoforms are required for mesenchymal condensation and chondrogenesis, neural crest haptotaxis, endocardial cushion formation, and ventricular septal morphogenesis [PMID:16257955, PMID:10851128, PMID:9758703, PMID:22692047]. Intronic VCAN mutations that shift splicing toward V2/V3 and one mutation that abolishes an MMP cleavage site in the GAGβ domain cause Wagner vitreoretinopathy through isoform imbalance and altered vitreous ECM rather than simple loss of function [PMID:16877430, PMID:22739342, PMID:30657523]. In disease, VCAN acts as a downstream effector of oncogenic and fibrotic programs—the Snail/PAPSS2 sulfation axis, TGF-β1/FAP, ERK5, and STAT5—and ADAMTS1 proteolysis of V1 generates fragments that transactivate EGFR to drive anoikis resistance and invasion [PMID:29955124, PMID:41800245, PMID:40617369, PMID:39333870].","teleology":[{"year":1986,"claim":"Established versican as a large embryonic CS proteoglycan that physically links hyaluronate to fibronectin and collagen, defining its core role as an ECM-organizing molecule whose distribution tracks mesenchymal condensation.","evidence":"Immunoprecipitation, affinity purification, and binding assays with multiple ECM ligands; metabolic labeling and immunofluorescence in chick limb bud","pmids":["3759976","3759975"],"confidence":"High","gaps":["Causal role in condensation inferred from localization, not loss-of-function","Domain responsible for each ligand interaction not yet mapped"]},{"year":1993,"claim":"cDNA cloning resolved the modular domain architecture (N-terminal HA-binding G1, C-terminal lectin/EGF/CRP G3) and revealed alternative splicing of two CS attachment domains, providing the structural framework for all subsequent isoform and domain studies.","evidence":"cDNA cloning, sequencing, and alternative splicing analysis","pmids":["8314802"],"confidence":"High","gaps":["Functional differences between V0–V3 isoforms not yet defined","Ligand specificity of each domain not yet tested"]},{"year":1995,"claim":"Defined the genomic basis of isoform generation (exon VII/CS-α and exon VIII/CS-β), establishing how V0–V3 arise and why splicing controls glycosaminoglycan content.","evidence":"Genomic DNA analysis, Northern, cDNA sequencing, PCR, Southern blotting","pmids":["7730339","7876137"],"confidence":"High","gaps":["Tissue-specific regulation of splicing not addressed","Phenotypic consequences of isoform loss not yet tested"]},{"year":1994,"claim":"Mapped the G3 domain's calcium-dependent C-type lectin and heparin-binding activities to the CRP-like module and identified versican as an anti-adhesive molecule regulating malignant adhesion phenotypes.","evidence":"GST-fusion expression, affinity chromatography, truncation mutagenesis; antisense suppression with adhesion/morphology readouts","pmids":["7961677","7531202"],"confidence":"High","gaps":["In vivo relevance of lectin/heparin binding not established","Mechanism of anti-adhesion (steric vs signaling) unresolved"]},{"year":2000,"claim":"Demonstrated that V0/V1 isoforms promote directed neural crest migration via HNK-1-bearing surface components and that versican binds midkine/pleiotrophin through CS chains, linking versican to growth-factor presentation and guidance.","evidence":"In situ hybridization, orthotopic implantation, 3D migration assay, chondroitinase; affinity purification and Kd binding assays with chondroitinase controls","pmids":["10851128","10866805"],"confidence":"High","gaps":["Identity of the HNK-1-bearing receptor not defined","Functional consequence of midkine binding in vivo not shown"]},{"year":2002,"claim":"Showed the G3 domain binds β1-integrin in a cation-dependent, non-RGD manner to activate FAK and confer apoptosis resistance, and that vascular isoforms promote platelet adhesion via dermatan sulfate, establishing versican as a signaling and hemostatic ligand.","evidence":"Pull-down, IP, FAK phosphorylation and apoptosis assays; platelet perfusion, GAG lyase digestion, affinity chromatography","pmids":["11805102","12468455"],"confidence":"High","gaps":["Platelet-surface 120-140 kDa receptor not molecularly identified","Integrin signaling downstream of FAK not fully traced"]},{"year":2003,"claim":"Localized both HA and link protein binding to the G1 B-B' subdomain and established that G3 intermolecular disulfide bonds stabilize matrix and cell-matrix interactions, defining the structural basis of aggregate assembly.","evidence":"BIAcore SPR with recombinant subdomains and molecular modeling; non-reducing SDS-PAGE and reducing-agent functional assays","pmids":["12888576","12846582"],"confidence":"High","gaps":["Stoichiometry of native aggregates in tissue not measured","Role of A subdomain in vivo not yet tested"]},{"year":2004,"claim":"Defined the G3 domain as a hub for tumor-promoting matrix signaling: it forms a fibronectin-VEGF trimeric complex driving angiogenesis, modulates EGFR-integrin crosstalk for anchorage-independent growth, and binds PSGL-1 to aggregate leukocytes.","evidence":"G3 and dominant-negative G3ΔEGF expression, co-IP of complexes, FAK/EGFR phosphorylation, soft agar and nude mouse tumor models, leukocyte aggregation assays","pmids":["14766798","15126624","15522894"],"confidence":"Medium","gaps":["EGF motif requirement for secretion vs signaling not fully separated","Plasma versican fragment source not defined"]},{"year":2007,"claim":"Showed HA-versican aggregates, not free HA, drive stromal and endothelial infiltration, confirming the assembled complex as the angiogenic functional unit.","evidence":"Matrigel plug assay comparing aggregates vs native HA with histology","pmids":["17322391"],"confidence":"Medium","gaps":["Receptor mediating aggregate-driven infiltration not identified","Contribution of specific isoform not resolved"]},{"year":1998,"claim":"Genetic disruption established versican as essential for endocardial cushion and right-ventricle formation, and later knock-in/knockout and exon-deletion models linked the G1 A subdomain and CS-rich isoforms to chondrogenesis, septal morphogenesis, and HA assembly/CD44-ERK-driven senescence.","evidence":"hdf insertional mutant, Cspg2Δ3/Δ3 and conditional Vcan knockout, exon 7 deletion mouse, antisense/chondroitinase/V3 overexpression with histology, migration, proliferation, ERK1/2 and senescence readouts","pmids":["9758703","16257955","16648631","19164294","22692047","24586547"],"confidence":"High","gaps":["Distinct contributions of individual isoforms in vivo only partially separated","Mechanism coupling HA fragment-CD44 signaling to senescence not fully traced"]},{"year":2006,"claim":"Resolved the genetic and structural basis of Wagner vitreoretinopathy as a splicing imbalance disorder—intronic mutations shifting toward V2/V3 and one mutation abolishing an MMP cleavage site in GAGβ—rather than simple loss of function.","evidence":"Linkage analysis, Sanger sequencing, RT-PCR/qRT-PCR of isoforms in patient tissues; FRET-based proteolysis assay and structural modeling","pmids":["16877430","22739342","30657523"],"confidence":"High","gaps":["How specific isoform ratio alters vitreous ECM mechanically not established","Tissue-to-tissue variability in isoform shift unexplained"]},{"year":2024,"claim":"Positioned VCAN as a convergent downstream effector of multiple oncogenic and fibrotic programs—Snail/PAPSS2, TGF-β1/FAP, ERK5, STAT5—and showed ADAMTS1 cleavage of V1 generates EGFR-transactivating fragments driving invasion and anoikis resistance.","evidence":"shRNA/overexpression epistasis and rescue, CHIP/luciferase, RTK arrays, co-IP, migration/invasion/anoikis assays, conditional knockout and xenograft/fibrosis mouse models","pmids":["29955124","37461061","41800245","39333870","40617369","39554845","39823128","39578365"],"confidence":"Medium","gaps":["PI3K/AKT placement downstream of VCAN largely inferred from inhibitor studies","Some downstream pathways (CD44-Hippo-SP1, Twist1) rest on single-study Co-IP without orthogonal validation"]},{"year":null,"claim":"How specific VCAN isoforms and their proteolytic fragments are selectively generated and read out by distinct receptors to produce context-dependent developmental versus disease outcomes remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model linking isoform/fragment identity to receptor choice","Receptors for several functional activities (platelet, HNK-1-mediated migration, aggregate infiltration) remain unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,2,16,18]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,10]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[9,13]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[9,12,14,25]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[0,1,16,19,20]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[14,18]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[0,10,16,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,7,15,20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[17,21,23,24,27,28]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,13,19,27]}],"complexes":["versican-hyaluronan-link protein aggregate","G3-fibronectin-VEGF trimeric complex"],"partners":["HAPLN1","FN1","VEGF","ITGB1","SELPLG","CD44","MDK","ADAMTS1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P13611","full_name":"Versican core protein","aliases":["Chondroitin sulfate proteoglycan core protein 2","Chondroitin sulfate proteoglycan 2","Glial hyaluronate-binding protein","GHAP","Large fibroblast proteoglycan","PG-M"],"length_aa":3396,"mass_kda":372.8,"function":"May play a role in intercellular signaling and in connecting cells with the extracellular matrix. May take part in the regulation of cell motility, growth and differentiation. Binds hyaluronic acid","subcellular_location":"Secreted, extracellular space, extracellular matrix; Cell projection, cilium, photoreceptor outer segment; Secreted, extracellular space, extracellular matrix, interphotoreceptor matrix; Secreted","url":"https://www.uniprot.org/uniprotkb/P13611/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/VCAN","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HEATR3","stoichiometry":0.2},{"gene":"RACK1","stoichiometry":0.2},{"gene":"SRP9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/VCAN","total_profiled":1310},"omim":[{"mim_id":"619726","title":"HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 2; HAPLN2","url":"https://www.omim.org/entry/619726"},{"mim_id":"611681","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 20; ADAMTS20","url":"https://www.omim.org/entry/611681"},{"mim_id":"607509","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 15; ADAMTS15","url":"https://www.omim.org/entry/607509"},{"mim_id":"605009","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 7; ADAMTS7","url":"https://www.omim.org/entry/605009"},{"mim_id":"602341","title":"FORKHEAD BOX M1; FOXM1","url":"https://www.omim.org/entry/602341"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Mid piece","reliability":"Approved"},{"location":"Principal piece","reliability":"Approved"},{"location":"End piece","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":171.7}],"url":"https://www.proteinatlas.org/search/VCAN"},"hgnc":{"alias_symbol":["PG-M"],"prev_symbol":["CSPG2"]},"alphafold":{"accession":"P13611","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P13611","model_url":"https://alphafold.ebi.ac.uk/files/AF-P13611-4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P13611-4-F1-predicted_aligned_error_v6.png","plddt_mean":85.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=VCAN","jax_strain_url":"https://www.jax.org/strain/search?query=VCAN"},"sequence":{"accession":"P13611","fasta_url":"https://rest.uniprot.org/uniprotkb/P13611.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P13611/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P13611"}},"corpus_meta":[{"pmid":"9758703","id":"PMC_9758703","title":"The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation.","date":"1998","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9758703","citation_count":270,"is_preprint":false},{"pmid":"3759975","id":"PMC_3759975","title":"A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo.","date":"1986","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3759975","citation_count":176,"is_preprint":false},{"pmid":"7822336","id":"PMC_7822336","title":"Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7822336","citation_count":157,"is_preprint":false},{"pmid":"8314802","id":"PMC_8314802","title":"cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8314802","citation_count":156,"is_preprint":false},{"pmid":"14766798","id":"PMC_14766798","title":"Versican/PG-M G3 domain promotes tumor growth and angiogenesis.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/14766798","citation_count":151,"is_preprint":false},{"pmid":"3759976","id":"PMC_3759976","title":"Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin.","date":"1986","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3759976","citation_count":143,"is_preprint":false},{"pmid":"17322391","id":"PMC_17322391","title":"Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M.","date":"2007","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17322391","citation_count":134,"is_preprint":false},{"pmid":"12888576","id":"PMC_12888576","title":"Distinct interaction of versican/PG-M with hyaluronan and link protein.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12888576","citation_count":121,"is_preprint":false},{"pmid":"10851128","id":"PMC_10851128","title":"Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10851128","citation_count":121,"is_preprint":false},{"pmid":"7876137","id":"PMC_7876137","title":"Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7876137","citation_count":113,"is_preprint":false},{"pmid":"11805102","id":"PMC_11805102","title":"beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11805102","citation_count":112,"is_preprint":false},{"pmid":"12221092","id":"PMC_12221092","title":"Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12221092","citation_count":103,"is_preprint":false},{"pmid":"29955124","id":"PMC_29955124","title":"Enhanced PAPSS2/VCAN sulfation axis is essential for Snail-mediated breast cancer cell migration and metastasis.","date":"2018","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/29955124","citation_count":98,"is_preprint":false},{"pmid":"7531202","id":"PMC_7531202","title":"Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican.","date":"1994","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/7531202","citation_count":91,"is_preprint":false},{"pmid":"8752156","id":"PMC_8752156","title":"2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8752156","citation_count":91,"is_preprint":false},{"pmid":"8342790","id":"PMC_8342790","title":"Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos.","date":"1993","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/8342790","citation_count":84,"is_preprint":false},{"pmid":"9088942","id":"PMC_9088942","title":"Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican.","date":"1997","source":"The Histochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9088942","citation_count":81,"is_preprint":false},{"pmid":"8641562","id":"PMC_8641562","title":"Inhibitory effects of PG-H/aggrecan and PG-M/versican on avian neural crest cell migration.","date":"1996","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/8641562","citation_count":78,"is_preprint":false},{"pmid":"10397680","id":"PMC_10397680","title":"Versican/PG-M isoforms in vascular smooth muscle cells.","date":"1999","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10397680","citation_count":74,"is_preprint":false},{"pmid":"22692047","id":"PMC_22692047","title":"Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development.","date":"2012","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22692047","citation_count":69,"is_preprint":false},{"pmid":"10866805","id":"PMC_10866805","title":"A heparin-binding growth factor, midkine, binds to a chondroitin sulfate proteoglycan, PG-M/versican.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10866805","citation_count":67,"is_preprint":false},{"pmid":"16877430","id":"PMC_16877430","title":"Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.","date":"2006","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16877430","citation_count":66,"is_preprint":false},{"pmid":"15522894","id":"PMC_15522894","title":"PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation.","date":"2004","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15522894","citation_count":63,"is_preprint":false},{"pmid":"16043844","id":"PMC_16043844","title":"Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome.","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16043844","citation_count":62,"is_preprint":false},{"pmid":"1478664","id":"PMC_1478664","title":"Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14).","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1478664","citation_count":59,"is_preprint":false},{"pmid":"14977887","id":"PMC_14977887","title":"The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/14977887","citation_count":56,"is_preprint":false},{"pmid":"16257955","id":"PMC_16257955","title":"Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16257955","citation_count":55,"is_preprint":false},{"pmid":"7730339","id":"PMC_7730339","title":"The gene structure and organization of mouse PG-M, a large chondroitin sulfate proteoglycan. Genomic background for the generation of multiple PG-M transcripts.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7730339","citation_count":51,"is_preprint":false},{"pmid":"37461061","id":"PMC_37461061","title":"TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37461061","citation_count":49,"is_preprint":false},{"pmid":"8640411","id":"PMC_8640411","title":"Distinct rat aortic smooth muscle cells differ in versican/PG-M expression.","date":"1996","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8640411","citation_count":48,"is_preprint":false},{"pmid":"15126624","id":"PMC_15126624","title":"Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin.","date":"2004","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15126624","citation_count":48,"is_preprint":false},{"pmid":"16648631","id":"PMC_16648631","title":"Identification and characterization of versican/PG-M aggregates in cartilage.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16648631","citation_count":47,"is_preprint":false},{"pmid":"7961677","id":"PMC_7961677","title":"Expression and binding activity of the carboxyl-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7961677","citation_count":43,"is_preprint":false},{"pmid":"19164294","id":"PMC_19164294","title":"Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19164294","citation_count":42,"is_preprint":false},{"pmid":"31637706","id":"PMC_31637706","title":"Long noncoding RNA VCAN-AS1 contributes to the progression of gastric cancer via regulating p53 expression.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31637706","citation_count":39,"is_preprint":false},{"pmid":"22739342","id":"PMC_22739342","title":"Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/22739342","citation_count":35,"is_preprint":false},{"pmid":"28869452","id":"PMC_28869452","title":"MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3'-UTR.","date":"2017","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/28869452","citation_count":34,"is_preprint":false},{"pmid":"8958811","id":"PMC_8958811","title":"Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty.","date":"1996","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/8958811","citation_count":34,"is_preprint":false},{"pmid":"10198161","id":"PMC_10198161","title":"Refined genetic and physical localization of the Wagner disease (WGN1) locus and the genes CRTL1 and CSPG2 to a 2- to 2.5-cM region of chromosome 5q14.3.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10198161","citation_count":33,"is_preprint":false},{"pmid":"12468455","id":"PMC_12468455","title":"Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12468455","citation_count":32,"is_preprint":false},{"pmid":"8530092","id":"PMC_8530092","title":"Expression pattern and mapping of the murine versican gene (Cspg2) to chromosome 13.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8530092","citation_count":31,"is_preprint":false},{"pmid":"9349562","id":"PMC_9349562","title":"Transient expression of PG-M/versican, a large chondroitin sulfate proteoglycan in developing chicken retina.","date":"1997","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9349562","citation_count":31,"is_preprint":false},{"pmid":"34130530","id":"PMC_34130530","title":"INHBA promotes the proliferation, migration and invasion of colon cancer cells through the upregulation of VCAN.","date":"2021","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/34130530","citation_count":30,"is_preprint":false},{"pmid":"31777586","id":"PMC_31777586","title":"Up-regulation of EMT-related gene VCAN by NPM1 mutant-driven TGF-β/cPML signalling promotes leukemia cell invasion.","date":"2019","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31777586","citation_count":28,"is_preprint":false},{"pmid":"18253748","id":"PMC_18253748","title":"Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion.","date":"2008","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18253748","citation_count":28,"is_preprint":false},{"pmid":"32922041","id":"PMC_32922041","title":"VUp-Regulation of VCAN Promotes the Proliferation, Invasion and Migration and Serves as a Biomarker in Gastric Cancer.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32922041","citation_count":26,"is_preprint":false},{"pmid":"21738396","id":"PMC_21738396","title":"A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.","date":"2011","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/21738396","citation_count":26,"is_preprint":false},{"pmid":"19901218","id":"PMC_19901218","title":"Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome.","date":"2009","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/19901218","citation_count":24,"is_preprint":false},{"pmid":"25606449","id":"PMC_25606449","title":"Association of Versican (VCAN) gene polymorphisms rs251124 and rs2287926 (G428D), with intracranial aneurysm.","date":"2014","source":"Meta gene","url":"https://pubmed.ncbi.nlm.nih.gov/25606449","citation_count":24,"is_preprint":false},{"pmid":"30657523","id":"PMC_30657523","title":"VCAN Canonical Splice Site Mutation is Associated With Vitreoretinal Degeneration and Disrupts an MMP Proteolytic Site.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/30657523","citation_count":20,"is_preprint":false},{"pmid":"24586547","id":"PMC_24586547","title":"Imbalanced expression of Vcan mRNA splice form proteins alters heart morphology and cellular protein profiles.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24586547","citation_count":20,"is_preprint":false},{"pmid":"32080097","id":"PMC_32080097","title":"The circ_VCAN with radioresistance contributes to the carcinogenesis of glioma by regulating microRNA-1183.","date":"2020","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32080097","citation_count":20,"is_preprint":false},{"pmid":"34293593","id":"PMC_34293593","title":"miR-543 impairs cell proliferation, migration, and invasion in breast cancer by suppressing VCAN.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/34293593","citation_count":19,"is_preprint":false},{"pmid":"34365889","id":"PMC_34365889","title":"Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34365889","citation_count":19,"is_preprint":false},{"pmid":"38267463","id":"PMC_38267463","title":"Collagen I-induced VCAN/ERK signaling and PARP1/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38267463","citation_count":19,"is_preprint":false},{"pmid":"11548223","id":"PMC_11548223","title":"Abnormal occurrence of a large chondroitin sulfate proteoglycan, PG-M/versican in osteoarthritic cartilage.","date":"1994","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/11548223","citation_count":18,"is_preprint":false},{"pmid":"16020278","id":"PMC_16020278","title":"Expression of a chondroitin sulfate proteoglycan, versican (PG-M), during development of rat cornea.","date":"2005","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/16020278","citation_count":16,"is_preprint":false},{"pmid":"10370116","id":"PMC_10370116","title":"Genetic analysis of steel and the PG-M/versican-encoding gene AxPG as candidates for the white (d) pigmentation mutant in the salamander Ambystoma mexicanum.","date":"1999","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/10370116","citation_count":16,"is_preprint":false},{"pmid":"12846582","id":"PMC_12846582","title":"G3 domains of aggrecan and PG-M/versican form intermolecular disulfide bonds that stabilize cell-matrix interaction.","date":"2003","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12846582","citation_count":15,"is_preprint":false},{"pmid":"16493581","id":"PMC_16493581","title":"Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.","date":"2006","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/16493581","citation_count":14,"is_preprint":false},{"pmid":"34692507","id":"PMC_34692507","title":"Circular RNA Circ-0002570 Accelerates Cancer Progression by Regulating VCAN via MiR-587 in Gastric Cancer.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34692507","citation_count":13,"is_preprint":false},{"pmid":"25968570","id":"PMC_25968570","title":"The Bacterial Component Flagellin Induces Anti-Sepsis Protection Through TLR-5, IL-1RN and VCAN During Polymicrobial Sepsis in Mice.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25968570","citation_count":13,"is_preprint":false},{"pmid":"30055036","id":"PMC_30055036","title":"Is exon 8 the most critical or the only dispensable exon of the VCAN gene? Insights into VCAN variants and clinical spectrum of Wagner syndrome.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30055036","citation_count":12,"is_preprint":false},{"pmid":"9013561","id":"PMC_9013561","title":"PG-M/versican-like proteoglycans are components of large disulfide-stabilized complexes in the axolotl embryo.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9013561","citation_count":12,"is_preprint":false},{"pmid":"36132055","id":"PMC_36132055","title":"JAM-A facilitates hair follicle regeneration in alopecia areata through functioning as ceRNA to protect VCAN expression in dermal papilla cells.","date":"2022","source":"Precision clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36132055","citation_count":11,"is_preprint":false},{"pmid":"36310697","id":"PMC_36310697","title":"VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors.","date":"2022","source":"World journal of gastrointestinal oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36310697","citation_count":10,"is_preprint":false},{"pmid":"37108649","id":"PMC_37108649","title":"VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37108649","citation_count":9,"is_preprint":false},{"pmid":"20053631","id":"PMC_20053631","title":"The intracranial aneurysm susceptibility genes HSPG2 and CSPG2 are not associated with abdominal aortic aneurysm.","date":"2010","source":"Angiology","url":"https://pubmed.ncbi.nlm.nih.gov/20053631","citation_count":9,"is_preprint":false},{"pmid":"11381620","id":"PMC_11381620","title":"Age differences in immunohistochemical localizations of large proteoglycan, PG-M/versican, and small proteoglycan, decorin, in the dermis of rats.","date":"2001","source":"Experimental animals","url":"https://pubmed.ncbi.nlm.nih.gov/11381620","citation_count":9,"is_preprint":false},{"pmid":"9344585","id":"PMC_9344585","title":"Reduced epidermal expression of a PG-M/versican-like proteoglycan in embryos of the white mutant axolotl.","date":"1997","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9344585","citation_count":9,"is_preprint":false},{"pmid":"32645906","id":"PMC_32645906","title":"Semen Modulates the Expression of NGF, ABHD2, VCAN, and CTEN in the Reproductive Tract of Female Rabbits.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32645906","citation_count":8,"is_preprint":false},{"pmid":"18484070","id":"PMC_18484070","title":"Chondroitin sulfate proteoglycan 2 (CSPG2) gene polymorphisms rs173686 and rs251124 are not associated with intracranial aneurysms in Chinese Han nationality.","date":"2007","source":"Upsala journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18484070","citation_count":8,"is_preprint":false},{"pmid":"36275632","id":"PMC_36275632","title":"Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36275632","citation_count":8,"is_preprint":false},{"pmid":"39333870","id":"PMC_39333870","title":"The oncogenic ADAMTS1-VCAN-EGFR cyclic axis drives anoikis resistance and invasion in renal cell carcinoma.","date":"2024","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/39333870","citation_count":7,"is_preprint":false},{"pmid":"39823128","id":"PMC_39823128","title":"The MIR181A2HG/miR-5680/VCAN-CD44 Axis Regulates Gastric Cancer Lymph Node Metastasis by Promoting M2 Macrophage Polarization.","date":"2025","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39823128","citation_count":6,"is_preprint":false},{"pmid":"32854301","id":"PMC_32854301","title":"Identification of Novel Copy Number Variations of VCAN Gene in Three Chinese Families with Wagner Disease.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32854301","citation_count":6,"is_preprint":false},{"pmid":"37032373","id":"PMC_37032373","title":"MiRNA-30a-5p/VCAN Arrests Tumor Metastasis via Modulating the Adhesion of Lung Adenocarcinoma Cells.","date":"2023","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37032373","citation_count":5,"is_preprint":false},{"pmid":"9797141","id":"PMC_9797141","title":"Differentiation of EL4 lymphoma cells by tumoral environment is associated with inappropriate expression of the large chondroitin sulfate proteoglycan PG-M and the tumor-associated antigen HTgp-175.","date":"1998","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9797141","citation_count":5,"is_preprint":false},{"pmid":"39578365","id":"PMC_39578365","title":"Promotor Hypomethylation Mediated Upregulation of VCAN Targets Twist1 to Promote EndMT in Hypoxia-Induced Pulmonary Hypertension.","date":"2024","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/39578365","citation_count":4,"is_preprint":false},{"pmid":"37833287","id":"PMC_37833287","title":"DSE inhibits melanoma progression by regulating tumor immune cell infiltration and VCAN.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37833287","citation_count":4,"is_preprint":false},{"pmid":"39849979","id":"PMC_39849979","title":"Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization.","date":"2025","source":"Diabetes & metabolism journal","url":"https://pubmed.ncbi.nlm.nih.gov/39849979","citation_count":3,"is_preprint":false},{"pmid":"40617369","id":"PMC_40617369","title":"STAT5/VCAN/PI3K signaling pathway promotes fibroblast activation and lung fibrosis.","date":"2025","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/40617369","citation_count":3,"is_preprint":false},{"pmid":"40101422","id":"PMC_40101422","title":"Resveratrol suppresses growth and VCAN expression in a Cancer-associated fibroblast-breast Cancer hybrid organoid.","date":"2025","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40101422","citation_count":3,"is_preprint":false},{"pmid":"34399281","id":"PMC_34399281","title":"Expression of VCAN and its receptors in canine mammary carcinomas with or without myoepithelial proliferation.","date":"2021","source":"Research in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/34399281","citation_count":3,"is_preprint":false},{"pmid":"39678543","id":"PMC_39678543","title":"Long non-coding RNA VCAN-AS1 promotes gastric cancer progression via the HuR/F11R pathway.","date":"2024","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/39678543","citation_count":3,"is_preprint":false},{"pmid":"39554845","id":"PMC_39554845","title":"VCAN in the extracellular matrix drives glioma recurrence by enhancing cell proliferation and migration.","date":"2024","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39554845","citation_count":3,"is_preprint":false},{"pmid":"36930067","id":"PMC_36930067","title":"COL3A1, CXCL8, VCAN, THBS2, and COL1A2 are correlated with the onset of biliary atresia.","date":"2023","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36930067","citation_count":3,"is_preprint":false},{"pmid":"40153926","id":"PMC_40153926","title":"Indole-3-lactic acid derived from tryptophan metabolism promotes trophoblast migration and invasion by activating the AhR/VCAN pathway.","date":"2025","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/40153926","citation_count":3,"is_preprint":false},{"pmid":"35137264","id":"PMC_35137264","title":"Downregulation of miR-23a-3p improves cognitive function in rats after subarachnoid hemorrhage by targeting VCAN.","date":"2022","source":"Medical molecular morphology","url":"https://pubmed.ncbi.nlm.nih.gov/35137264","citation_count":3,"is_preprint":false},{"pmid":"37854213","id":"PMC_37854213","title":"Pan-cancer analysis of the oncogenic role of the core osteosarcoma gene VCAN in human tumors.","date":"2023","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/37854213","citation_count":3,"is_preprint":false},{"pmid":"36333947","id":"PMC_36333947","title":"A novel splicing variant of VCAN identified in a Chinese family initially diagnosed with familial exudative vitreoretinopathy.","date":"2022","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36333947","citation_count":3,"is_preprint":false},{"pmid":"23568740","id":"PMC_23568740","title":"[Association of single nucleotide polymorphisms of CSPG2 and HSPG2 genes with intracranial aneurysm in ethnic Han Chinese population].","date":"2013","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23568740","citation_count":3,"is_preprint":false},{"pmid":"31970092","id":"PMC_31970092","title":"The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis.","date":"2019","source":"Iranian journal of public health","url":"https://pubmed.ncbi.nlm.nih.gov/31970092","citation_count":2,"is_preprint":false},{"pmid":"36378611","id":"PMC_36378611","title":"Multimodal Retinal Imaging Findings in Two Cousins With VCAN-Related Vitreoretinopathy or Wagner Disease.","date":"2022","source":"Ophthalmic surgery, lasers & imaging retina","url":"https://pubmed.ncbi.nlm.nih.gov/36378611","citation_count":2,"is_preprint":false},{"pmid":"36837392","id":"PMC_36837392","title":"Sevoflurane Exposure of Clinical Doses in Pregnant Rats Induces Vcan Changes without Significant Neural Apoptosis in the Offspring.","date":"2023","source":"Medicina (Kaunas, Lithuania)","url":"https://pubmed.ncbi.nlm.nih.gov/36837392","citation_count":2,"is_preprint":false},{"pmid":"41555841","id":"PMC_41555841","title":"Bulk Sequencing Combined With Single-Cell Sequencing Identifies High Expression of VCAN in Fibroblasts Promoting the Progression of High-Stemness Gastric Adenocarcinoma Cells.","date":"2026","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/41555841","citation_count":1,"is_preprint":false},{"pmid":"40747711","id":"PMC_40747711","title":"Visfatin facilitates esophageal cancer migration by suppressing miR‑3613‑5p expression and promoting VEZF1/VCAN production.","date":"2025","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/40747711","citation_count":0,"is_preprint":false},{"pmid":"41800245","id":"PMC_41800245","title":"VCAN Is Essential for ERK5-Driven Tumorigenesis in Soft Tissue Sarcoma.","date":"2026","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41800245","citation_count":0,"is_preprint":false},{"pmid":"38685004","id":"PMC_38685004","title":"Clinical significance and potential pathogenesis of VCAN in adult non-cystic fibrosis bronchiectasis: a retrospective study.","date":"2024","source":"BMC pulmonary medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38685004","citation_count":0,"is_preprint":false},{"pmid":"41720002","id":"PMC_41720002","title":"Trichosanthes kirilowii extract alleviated liver fibrosis and acute myocardial infarction by inhibiting VCAN to restrain monocyte senescence: Insights from bioinformatic analyses and experimental validation.","date":"2026","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41720002","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52294,"output_tokens":8488,"usd":0.142101,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18342,"output_tokens":4811,"usd":0.105993,"stage2_stop_reason":"end_turn"},"total_usd":0.248094,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1986,\n      \"finding\": \"PG-M (versican) binds directly to fibronectin and type I collagen, but not to laminin or type IV collagen, and mediates binding of hyaluronate to cellular fibronectin; the hyaluronate-binding activity in fibronectin preparations was immunoprecipitable with anti-PG-M antibody, demonstrating that PG-M is responsible for this activity.\",\n      \"method\": \"Immunoprecipitation, affinity purification, CsCl isopycnic centrifugation, binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal immunoprecipitation plus direct binding assays with multiple ECM ligands tested, replicated across different cell sources\",\n      \"pmids\": [\"3759976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"PG-M (versican) is synthesized as the predominant large chondroitin sulfate proteoglycan in chick embryo limb buds before chondrogenesis, with a core protein of ~550 kDa, and its distribution closely follows mesenchymal cell condensation, suggesting a role in the condensation process.\",\n      \"method\": \"Metabolic labeling with [35S]sulfate, CsCl isopycnic centrifugation, SDS-PAGE, tryptic peptide mapping, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical and histological methods in single lab; functional role inferred from localization\",\n      \"pmids\": [\"3759975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The PG-M/versican core protein contains an N-terminal hyaluronan-binding domain and C-terminal EGF-like domains, a C-type lectin-like domain, and a complement regulatory protein (CRP)-like domain, as deduced from cDNA sequence analysis; multiple alternatively spliced isoforms (V0, V1, V2, V3) are generated by alternative usage of two chondroitin sulfate attachment domains (CS-α and CS-β).\",\n      \"method\": \"cDNA cloning and sequencing, alternative splicing analysis, homology analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — primary structural determination by cDNA sequencing confirmed in multiple subsequent studies\",\n      \"pmids\": [\"8314802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The C-terminal (G3) domain of PG-M binds D-mannose, D-galactose, L-fucose, and N-acetyl-D-glucosamine in a calcium-dependent manner (C-type lectin activity), and also binds heparin/heparan sulfate; both activities require the intact CRP-like domain, as removal of this domain abolishes both C-type lectin and heparin binding activities.\",\n      \"method\": \"Expression of GST-fusion protein, affinity chromatography, truncation mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding assays with recombinant protein and domain deletion mutagenesis in single lab with clear mechanistic readout\",\n      \"pmids\": [\"7961677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"PG-M/versican acts as an anti-adhesive molecule; it is excluded from focal contacts of fibroblasts and from podosomes of osteosarcoma cells, and antisense-mediated suppression of PG-M/versican biosynthesis suppresses the malignant podosome-type adhesion phenotype of human osteosarcoma cells.\",\n      \"method\": \"Antisense inhibition, immunofluorescence localization, cell adhesion assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — antisense loss-of-function with specific morphological phenotype readout, supported by localization data, single lab\",\n      \"pmids\": [\"7531202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Multiple PG-M isoforms (V0 containing both CS-α and CS-β domains, V1 with CS-β only, V2 with CS-α only, and V3 with neither) are generated from a single genomic locus by alternative splicing of two large exons (exon VII encoding CS-α, 2880 bp; exon VIII encoding CS-β, 5229 bp); the V3 isoform lacks any chondroitin sulfate attachment region.\",\n      \"method\": \"Genomic DNA analysis, Northern hybridization, cDNA sequencing, PCR, Southern blotting\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — primary genomic structural determination confirmed by multiple methods; replicated across species\",\n      \"pmids\": [\"7730339\", \"7876137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Normal expression of the Cspg2 (versican) gene is required for formation of endocardial cushion swellings and the embryonic heart segments that give rise to the right ventricle and conus/truncus; hdf mice carrying a transgene insertional mutation disrupting Cspg2 die in utero by E10.5 and completely lack endocardial cushions and right cardiac chamber.\",\n      \"method\": \"Transgene insertional mutagenesis, chromosome mapping, immunohistochemistry, expression analysis (exon boundary PCR), genomic cloning\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — four independent lines of evidence (mapping, IHC, expression analysis, genomic sequencing) establishing loss-of-function cardiac phenotype\",\n      \"pmids\": [\"9758703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PG-M/versicans V0 and V1 isoforms are expressed along neural crest migratory pathways and promote directed (haptotactic) neural crest cell migration via HNK-1 antigen-bearing cell surface components; orthotopic implantation of PG-M/versican attracts migrating neural crest cells, whereas aggrecan retains them. Inhibitory effect of aggrecan on neural crest migration requires intact G1 domain-mediated association with cell-surface hyaluronan.\",\n      \"method\": \"In situ hybridization, immunohistochemistry, TEM/rotary shadowing, orthotopic microsphere implantation, 3D collagen migration assay, chondroitinase treatment\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vitro and in vivo methods establishing mechanistic divergence between versican and aggrecan on neural crest migration\",\n      \"pmids\": [\"10851128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PG-M/versican binds midkine (a heparin-binding growth factor) with Kd of 1.0 nM through the chondroitin sulfate chains; binding requires polysulfated regions and is abolished by chondroitinase ABC digestion; pleiotrophin binds similarly.\",\n      \"method\": \"Affinity purification, in-gel trypsin digestion/peptide sequencing, binding assay, chondroitinase digestion, competition with heparin/CS variants\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay with Kd determination and enzyme digestion to map binding domain, single lab\",\n      \"pmids\": [\"10866805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The C-terminal G3 domain of PG-M/versican binds β1-integrin in a calcium- and manganese-dependent manner (not via RGD motif); this interaction activates focal adhesion kinase, enhances integrin expression, promotes cell adhesion, and confers resistance to free radical-induced apoptosis.\",\n      \"method\": \"Pull-down assay, immunoprecipitation, cell-surface binding assay, native gel electrophoresis, FAK phosphorylation assay, apoptosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal binding assays plus functional downstream signaling and apoptosis readouts in single lab\",\n      \"pmids\": [\"11805102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Versican/PG-M G1 domain binds both hyaluronan (HA) and link protein (LP); the B-B' subdomain of the G1 domain is sufficient for both HA and LP binding; the A subdomain enhances HA binding but has negligible effect on LP binding. A structural model of B-B' identifies deletion/insertion features critical for stable structure and HA binding.\",\n      \"method\": \"BIAcore surface plasmon resonance, recombinant subdomain expression, overlay sensorgrams, molecular modeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SPR binding kinetics with recombinant domain constructs and molecular modeling, single lab but rigorous\",\n      \"pmids\": [\"12888576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The G3 domains of PG-M/versican and aggrecan form intermolecular disulfide bonds involving all subdomains and all 10 cysteine residues; disruption of these disulfide bonds with reducing agents disrupts chondrocyte-matrix interaction, alters ECM structure, and reduces G3 domain-mediated cell adhesion.\",\n      \"method\": \"Recombinant protein expression, non-reducing SDS-PAGE, reducing agent treatment, chondrocyte-matrix interaction assay, cell adhesion assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution with disulfide bond disruption and functional readouts, single lab\",\n      \"pmids\": [\"12846582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Versican G3 domain directly binds fibronectin and forms a trimeric complex with fibronectin and VEGF; this complex enhances endothelial cell adhesion, proliferation, and migration, and G3-expressing tumor cells show increased fibronectin and VEGF expression and enhanced angiogenesis in vivo.\",\n      \"method\": \"G3 construct expression in U87 cells, soft agarose colony assay, nude mouse tumor model, endothelial cell adhesion/proliferation/migration assays, co-immunoprecipitation of G3-fibronectin-VEGF complex\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal in vitro and in vivo methods with direct complex identification, single lab\",\n      \"pmids\": [\"14766798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Versican G3 domain lacking EGF-like motifs (G3ΔEGF) acts as a dominant-negative, impairs versican secretion, enhances tumor cell adhesion, and prevents anchorage-independent growth. This mutant sustains FAK phosphorylation and integrin-EGFR association after serum withdrawal but reduces EGFR phosphorylation, demonstrating that the versican G3 domain modulates EGFR-integrin crosstalk to promote tumorigenesis.\",\n      \"method\": \"Dominant-negative G3ΔEGF transfection, FAK phosphorylation assay, co-immunoprecipitation of integrin-EGFR, soft agar growth assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative approach with signaling readouts and functional assays, single lab\",\n      \"pmids\": [\"15126624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PG-M/versican G3 domain binds P-selectin glycoprotein ligand-1 (PSGL-1); versican G3 multimers bridge PSGL-1-expressing leukocytes to induce leukocyte aggregation; endogenous G3-containing versican fragments in human plasma contribute to leukocyte aggregation, and removal of these fragments reduces the effect.\",\n      \"method\": \"Transfection, cell aggregation assay, PSGL-1 binding assays, human plasma depletion experiments, mouse model\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vitro and in vivo systems confirming binding and functional consequence, single lab\",\n      \"pmids\": [\"15522894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Versican/PG-M is required for mesenchymal condensation and chondrogenesis; chondrogenic stimuli upregulate V0 and V1 isoforms (containing more CS chains); antisense suppression of versican reduces chondrogenesis; chondroitinase ABC treatment or β-xyloside treatment (inhibiting CS chain addition to core proteins) suppresses chondrogenesis; forced expression of V3 (no CS chains) disrupts native versican organization and inhibits chondrogenesis.\",\n      \"method\": \"Antisense stable clones, chondroitinase ABC treatment, β-xyloside treatment, V3 overexpression, aggrecan deposition assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple loss-of-function approaches (antisense, enzyme digestion, chain synthesis inhibition, dominant-negative V3) all converging on same phenotype\",\n      \"pmids\": [\"16257955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Versican/PG-M is present in articular cartilage as a proteoglycan aggregate with both link protein and hyaluronan (distinct from the aggrecan aggregate); its CS chains are predominantly nonsulfated (71%) and 4-sulfated (28%). Link protein overexpression enhances versican matrix deposition and prevents subsequent aggrecan deposition.\",\n      \"method\": \"Immunostaining, biochemical analysis of aggrecan-null (cmd/cmd) cartilage, chondroitinase ABC digestion/disaccharide analysis, link protein overexpression in N1511 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical characterization with genetic controls (aggrecan-null mice) and overexpression experiment, single lab\",\n      \"pmids\": [\"16648631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Intronic mutations in CSPG2/VCAN at the splice acceptor site of intron 7 cause Wagner disease and erosive vitreoretinopathy by shifting the balance of splice variants: a >38-fold increase in V2 and >12-fold increase in V3 isoforms is consistently observed in patient tissues, representing a disease mechanism based on isoform imbalance rather than simple loss of function.\",\n      \"method\": \"Genetic linkage analysis, Sanger sequencing of CSPG2, RT-PCR of splice variants, quantitative RT-PCR (QPCR) in patient-derived tissues\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative splice variant analysis across multiple families showing consistent isoform imbalance as pathogenic mechanism; replicated in multiple families and subsequent studies\",\n      \"pmids\": [\"16877430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Hyaluronan-versican aggregates (but not native hyaluronan alone) promote stromal cell recruitment and endothelial cell infiltration in Matrigel plug angiogenesis assays, indicating that the versican-HA complex is required for the pro-angiogenic activity.\",\n      \"method\": \"Matrigel plug assay, comparison of hyaluronan-versican aggregates vs. native HA, histological analysis of stromal/endothelial cell infiltration\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo comparison with purified complexes, single lab, clear mechanistic readout\",\n      \"pmids\": [\"17322391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Versican/PG-M is essential for assembling hyaluronan into extracellular matrix; knock-in mice (Cspg2Δ3/Δ3) lacking the A subdomain of the G1 domain show decreased versican and HA deposition, increased free HA fragments that interact with CD44, elevated ERK1/2 phosphorylation, and premature cellular senescence. Wild-type fibroblast treatment with hyaluronidase or exogenous HA enhances ERK1/2 phosphorylation via CD44; anti-CD44 antibody blocking inhibits this phosphorylation.\",\n      \"method\": \"Knock-in mouse model, ECM network immunofluorescence, anti-CD44 blocking antibody, ERK1/2 phosphorylation assay, senescence marker analysis (p53, p21, p16), exogenous HA/hyaluronidase treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic model with multiple orthogonal mechanistic readouts linking versican's HA-organizing function to CD44-ERK signaling and senescence\",\n      \"pmids\": [\"19164294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Versican/PG-M is required for ventricular septal formation subsequent to AV cushion development; Vcan knockout mice (Vcan Δ3/Δ3) show smaller AV cushions with narrowed ECM/cardiac jelly space, condensed HA without versican, and ventricular septal defects; ex vivo explant culture shows impaired cell migration in these regions. The A subdomain of the G1 domain is essential for proper proteoglycan aggregate formation and interventricular septal morphogenesis.\",\n      \"method\": \"Conditional Vcan knockout mouse, immunostaining, Ki67 proliferation assay, ex vivo collagen gel explant migration assay\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout model with specific histological and functional mechanistic readouts, ex vivo validation\",\n      \"pmids\": [\"22692047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Novel splice acceptor and donor-site mutations in VCAN (introns 7 and 8) cause Wagner syndrome through a pathogenic mechanism of increased transcript variants lacking exons 7 and/or 8, with reduction in glycosaminoglycan modifications; the magnitude of the isoform shift varies between tissues and mutations.\",\n      \"method\": \"Family-based genetic linkage, Sanger sequencing, qRT-PCR of isoforms in patient-derived venous blood and skin fibroblasts\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — qRT-PCR isoform analysis in patient-derived tissues across three independent families, mechanistic model confirmed at RNA level\",\n      \"pmids\": [\"22739342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Imbalanced expression of Vcan splice forms (deletion of exon 7 prevents V0 and V2 expression) results in ventricular septal defects, smaller valve cushions with diminished myocardialization, and altered outflow tracts; proteomic profiling of Vcan(tm1Zim) hearts identifies compensatory changes in cytoskeletal and muscle contraction proteins.\",\n      \"method\": \"Exon 7 deletion mouse model (Vcan(tm1Zim)), histology, large-scale differential protein expression profiling (proteomics)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic model with proteomic profiling; consistent with other Vcan loss-of-function cardiac studies but single lab\",\n      \"pmids\": [\"24586547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A VCAN splice site mutation (c.4004-2A>G) eliminates an MMP cleavage site in the GAGβ chain (VCAN p.1335-1347 deletion), validated by FRET-based proteolysis assays; loss of this MMP cleavage site alters versican structure and results in abnormal vitreous ECM modeling, causing vitreoretinal degeneration.\",\n      \"method\": \"Sanger sequencing, protein structural modeling, FRET-based in vitro proteolysis assay, proteomic network analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — FRET proteolysis assay directly demonstrates MMP cleavage site loss; structural modeling supports mechanism; single lab\",\n      \"pmids\": [\"30657523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Snail induces co-expression of PAPSS2 (rate-limiting enzyme in sulfation) and VCAN in breast cancer cells; depletion of VCAN dampens the cell migration activity induced by Snail or PAPSS2 in MCF 10A cells, establishing VCAN as a downstream effector in the Snail/PAPSS2 sulfation axis driving EMT and metastasis.\",\n      \"method\": \"shRNA knockdown, overexpression, cell migration assay, in vivo lung metastasis model (nude mice), PAPSS inhibitor (sodium chlorate) treatment\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic and pharmacological loss-of-function approaches with in vitro and in vivo metastasis readouts, single lab\",\n      \"pmids\": [\"29955124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Vascular PG-M/versican isoforms V1 and V2 promote platelet adhesion in a shear rate-dependent manner primarily through their dermatan sulfate chains; versicans incorporated into fibrillar collagen strongly promote platelet aggregation at both low and high shear rates; a 120-140 kDa polypeptide complex on the platelet surface serves as the versican-binding membrane ligand.\",\n      \"method\": \"Real-time platelet perfusion assay, glycosaminoglycan lyase digestion, competition with purified GAGs, affinity chromatography on DS-Sepharose, solid-phase binding assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (perfusion, enzyme digestion, affinity chromatography) establishing mechanism of platelet-versican interaction, single lab\",\n      \"pmids\": [\"12468455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TGF-β1 derived from stromal fibroblasts upregulates FAP in fibroblasts, which in turn upregulates VCAN as a downstream molecule; VCAN plays an essential role in TGF-β1/FAP axis-induced EMT in bladder cancer cells potentially through PI3K/AKT1 signaling pathway.\",\n      \"method\": \"Primary CAF isolation, conditioned medium co-culture system, cytokine antibody array, gene set enrichment analysis, shRNA knockdown, cell migration/invasion assays\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — functional assays in co-culture system but PI3K/AKT1 mechanism only proposed, not directly validated for VCAN specifically; single lab\",\n      \"pmids\": [\"37461061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ADAMTS1 proteolytically cleaves versican V1 (VCAN V1), generating fragments that activate EGFR transactivation, which drives anoikis resistance and invasion in renal cell carcinoma; ADAMTS1 also forms a complex with p53 to modulate EGFR signaling. VCAN knockdown reverses ADAMTS1-induced pro-metastatic characteristics in vivo.\",\n      \"method\": \"RTK array screening, IP assays, luciferase reporter assays, western blotting, RT-qPCR, anoikis resistance assays, invasion assays, zebrafish xenotransplantation\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (IP, luciferase, functional assays, in vivo model) establishing ADAMTS1-VCAN-EGFR axis, single lab\",\n      \"pmids\": [\"39333870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"STAT5 acts as a transcription factor that promotes VCAN expression upon bleomycin induction; elevated VCAN promotes fibroblast activation through the PI3K signaling pathway; fibroblast-specific VCAN knockout significantly reduces lung fibroblast activation and lung fibrosis in mice.\",\n      \"method\": \"Fibroblast-specific conditional VCAN knockout mice, Western blot, immunohistochemistry, immunofluorescence, chromatin immunoprecipitation (CHIP), luciferase reporter gene analysis, PI3K inhibitor treatment, bleomycin/radiation fibrosis models\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse with mechanistic validation of STAT5 transcriptional regulation and PI3K pathway downstream, multiple methods in single lab\",\n      \"pmids\": [\"40617369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"VCAN interacts with CD44 receptors on tumor-associated macrophages via paracrine secretion, promoting M2 macrophage polarization and VEGF-C secretion to facilitate lymphangiogenesis; VCAN also binds CD44 on gastric cancer cells via autocrine secretion, activating the Hippo pathway and upregulating SP1 to promote MIR181A2HG transcription, establishing a feedback loop.\",\n      \"method\": \"Co-IP, RNA-pulldown, luciferase reporter assay, CHIP, immunofluorescence, ELISA, in vitro and in vivo functional studies\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — CD44 interaction and downstream pathway supported by Co-IP and reporter assays, but complex multi-step mechanism established in single study with limited orthogonal validation of each step\",\n      \"pmids\": [\"39823128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"VCAN is identified as a transcriptional target of ERK5 in soft tissue sarcoma; VCAN silencing phenocopies ERK5 silencing (impaired migration, adhesion, proliferation, tumorigenesis) and VCAN overexpression rescues ERK5 silencing phenotypes, confirming VCAN as an essential downstream mediator of ERK5-driven oncogenesis.\",\n      \"method\": \"shRNA silencing, overexpression, pharmacological ERK5 inhibition, migration/adhesion/proliferation/tumorigenesis assays, murine sarcoma model, transcriptomic profiling, human biopsy analysis (mRNA/protein)\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via silencing and rescue experiments with multiple functional readouts, murine and human validation, single lab\",\n      \"pmids\": [\"41800245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Versican promotes glioma cell proliferation and migration through the PI3K/Akt/AP-1 signaling pathway; PI3K/Akt pathway inhibition blocks VCAN-mediated glioma progression.\",\n      \"method\": \"VCAN overexpression in glioma cell lines, PI3K/Akt inhibitor treatment, functional proliferation and migration assays, transcriptomic analysis\",\n      \"journal\": \"Frontiers in neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — overexpression with pathway inhibitor, single lab, limited mechanistic depth for pathway placement\",\n      \"pmids\": [\"39554845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Promoter hypomethylation (mediated by reduced DNA methyltransferase activity under hypoxia) upregulates versican expression; versican promotes endothelial-to-mesenchymal transition (EndMT) by targeting the transcription factor Twist1, driving pulmonary hypertension progression; endothelium-specific versican knockdown reverses HPH and prevents EndMT.\",\n      \"method\": \"Co-immunoprecipitation (versican-Twist1 interaction), Western blot, immunohistochemistry, immunofluorescence, methylation-specific PCR, endothelium-specific knockdown in mouse HPH model, hemodynamic measurements\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for direct protein interaction plus conditional KO model and epigenetic mechanism, single lab\",\n      \"pmids\": [\"39578365\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"VCAN/versican (CSPG2/PG-M) is a large modular chondroitin sulfate proteoglycan whose N-terminal G1 domain binds hyaluronan (via the B-B' subdomains) and link protein to form proteoglycan aggregates in the ECM, while its C-terminal G3 domain mediates calcium-dependent lectin-type binding to sugars and heparin, binds fibronectin, VEGF, β1-integrin (non-RGD), and PSGL-1, and forms stabilizing intermolecular disulfide bonds; alternatively spliced isoforms (V0–V3) differing in chondroitin sulfate attachment domain content are expressed in a tissue- and developmental stage-specific manner, with the V0/V1 CS-rich isoforms required for mesenchymal condensation, cardiac cushion/septal morphogenesis, and neural crest migration, and splicing imbalance (excess V2/V3) caused by intronic VCAN mutations—disrupting an MMP cleavage site in the GAGβ domain—underlying Wagner vitreoretinopathy; in cancer, VCAN acts downstream of Snail/PAPSS2 sulfation, TGF-β1/FAP, ERK5, and ADAMTS1 proteolysis (which releases versican fragments that transactivate EGFR), and promotes cell migration, EMT, and anoikis resistance, while versican-assembled HA matrices regulate CD44-ERK1/2 signaling and cellular senescence, and STAT5 drives VCAN transcription to activate PI3K-dependent fibroblast activation in pulmonary fibrosis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"VCAN (versican/PG-M/CSPG2) is a large modular chondroitin sulfate proteoglycan that organizes the extracellular matrix and transduces matrix signals controlling cell adhesion, migration, condensation, and morphogenesis [#1, #2]. Its N-terminal G1 domain binds hyaluronan and link protein to assemble proteoglycan aggregates, with the B-B' subdomain sufficient for both interactions and the A subdomain enhancing hyaluronan binding and required for stable aggregate formation [#10, #16]; this hyaluronan-organizing function is essential for ECM assembly, and its loss releases free HA fragments that engage CD44, elevate ERK1/2 phosphorylation, and trigger premature senescence [#19]. The C-terminal G3 domain provides calcium-dependent C-type lectin and heparin-binding activities dependent on the CRP-like module, mediates intermolecular disulfide bonding, and engages fibronectin, VEGF, non-RGD β1-integrin, and PSGL-1 to activate FAK, support adhesion, confer apoptosis resistance, promote angiogenesis, and bridge leukocytes [#3, #11, #9, #12, #14]. The core protein is expressed as alternatively spliced isoforms V0–V3 differing in CS-α and CS-β attachment domain content [#2, #5], and the CS-rich V0/V1 isoforms are required for mesenchymal condensation and chondrogenesis, neural crest haptotaxis, endocardial cushion formation, and ventricular septal morphogenesis [#15, #7, #6, #20]. Intronic VCAN mutations that shift splicing toward V2/V3 and one mutation that abolishes an MMP cleavage site in the GAGβ domain cause Wagner vitreoretinopathy through isoform imbalance and altered vitreous ECM rather than simple loss of function [#17, #21, #23]. In disease, VCAN acts as a downstream effector of oncogenic and fibrotic programs—the Snail/PAPSS2 sulfation axis, TGF-β1/FAP, ERK5, and STAT5—and ADAMTS1 proteolysis of V1 generates fragments that transactivate EGFR to drive anoikis resistance and invasion [#24, #30, #28, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 1986,\n      \"claim\": \"Established versican as a large embryonic CS proteoglycan that physically links hyaluronate to fibronectin and collagen, defining its core role as an ECM-organizing molecule whose distribution tracks mesenchymal condensation.\",\n      \"evidence\": \"Immunoprecipitation, affinity purification, and binding assays with multiple ECM ligands; metabolic labeling and immunofluorescence in chick limb bud\",\n      \"pmids\": [\"3759976\", \"3759975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal role in condensation inferred from localization, not loss-of-function\", \"Domain responsible for each ligand interaction not yet mapped\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"cDNA cloning resolved the modular domain architecture (N-terminal HA-binding G1, C-terminal lectin/EGF/CRP G3) and revealed alternative splicing of two CS attachment domains, providing the structural framework for all subsequent isoform and domain studies.\",\n      \"evidence\": \"cDNA cloning, sequencing, and alternative splicing analysis\",\n      \"pmids\": [\"8314802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional differences between V0–V3 isoforms not yet defined\", \"Ligand specificity of each domain not yet tested\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined the genomic basis of isoform generation (exon VII/CS-α and exon VIII/CS-β), establishing how V0–V3 arise and why splicing controls glycosaminoglycan content.\",\n      \"evidence\": \"Genomic DNA analysis, Northern, cDNA sequencing, PCR, Southern blotting\",\n      \"pmids\": [\"7730339\", \"7876137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific regulation of splicing not addressed\", \"Phenotypic consequences of isoform loss not yet tested\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Mapped the G3 domain's calcium-dependent C-type lectin and heparin-binding activities to the CRP-like module and identified versican as an anti-adhesive molecule regulating malignant adhesion phenotypes.\",\n      \"evidence\": \"GST-fusion expression, affinity chromatography, truncation mutagenesis; antisense suppression with adhesion/morphology readouts\",\n      \"pmids\": [\"7961677\", \"7531202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of lectin/heparin binding not established\", \"Mechanism of anti-adhesion (steric vs signaling) unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated that V0/V1 isoforms promote directed neural crest migration via HNK-1-bearing surface components and that versican binds midkine/pleiotrophin through CS chains, linking versican to growth-factor presentation and guidance.\",\n      \"evidence\": \"In situ hybridization, orthotopic implantation, 3D migration assay, chondroitinase; affinity purification and Kd binding assays with chondroitinase controls\",\n      \"pmids\": [\"10851128\", \"10866805\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the HNK-1-bearing receptor not defined\", \"Functional consequence of midkine binding in vivo not shown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed the G3 domain binds β1-integrin in a cation-dependent, non-RGD manner to activate FAK and confer apoptosis resistance, and that vascular isoforms promote platelet adhesion via dermatan sulfate, establishing versican as a signaling and hemostatic ligand.\",\n      \"evidence\": \"Pull-down, IP, FAK phosphorylation and apoptosis assays; platelet perfusion, GAG lyase digestion, affinity chromatography\",\n      \"pmids\": [\"11805102\", \"12468455\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Platelet-surface 120-140 kDa receptor not molecularly identified\", \"Integrin signaling downstream of FAK not fully traced\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Localized both HA and link protein binding to the G1 B-B' subdomain and established that G3 intermolecular disulfide bonds stabilize matrix and cell-matrix interactions, defining the structural basis of aggregate assembly.\",\n      \"evidence\": \"BIAcore SPR with recombinant subdomains and molecular modeling; non-reducing SDS-PAGE and reducing-agent functional assays\",\n      \"pmids\": [\"12888576\", \"12846582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of native aggregates in tissue not measured\", \"Role of A subdomain in vivo not yet tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the G3 domain as a hub for tumor-promoting matrix signaling: it forms a fibronectin-VEGF trimeric complex driving angiogenesis, modulates EGFR-integrin crosstalk for anchorage-independent growth, and binds PSGL-1 to aggregate leukocytes.\",\n      \"evidence\": \"G3 and dominant-negative G3ΔEGF expression, co-IP of complexes, FAK/EGFR phosphorylation, soft agar and nude mouse tumor models, leukocyte aggregation assays\",\n      \"pmids\": [\"14766798\", \"15126624\", \"15522894\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"EGF motif requirement for secretion vs signaling not fully separated\", \"Plasma versican fragment source not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed HA-versican aggregates, not free HA, drive stromal and endothelial infiltration, confirming the assembled complex as the angiogenic functional unit.\",\n      \"evidence\": \"Matrigel plug assay comparing aggregates vs native HA with histology\",\n      \"pmids\": [\"17322391\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating aggregate-driven infiltration not identified\", \"Contribution of specific isoform not resolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Genetic disruption established versican as essential for endocardial cushion and right-ventricle formation, and later knock-in/knockout and exon-deletion models linked the G1 A subdomain and CS-rich isoforms to chondrogenesis, septal morphogenesis, and HA assembly/CD44-ERK-driven senescence.\",\n      \"evidence\": \"hdf insertional mutant, Cspg2Δ3/Δ3 and conditional Vcan knockout, exon 7 deletion mouse, antisense/chondroitinase/V3 overexpression with histology, migration, proliferation, ERK1/2 and senescence readouts\",\n      \"pmids\": [\"9758703\", \"16257955\", \"16648631\", \"19164294\", \"22692047\", \"24586547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distinct contributions of individual isoforms in vivo only partially separated\", \"Mechanism coupling HA fragment-CD44 signaling to senescence not fully traced\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved the genetic and structural basis of Wagner vitreoretinopathy as a splicing imbalance disorder—intronic mutations shifting toward V2/V3 and one mutation abolishing an MMP cleavage site in GAGβ—rather than simple loss of function.\",\n      \"evidence\": \"Linkage analysis, Sanger sequencing, RT-PCR/qRT-PCR of isoforms in patient tissues; FRET-based proteolysis assay and structural modeling\",\n      \"pmids\": [\"16877430\", \"22739342\", \"30657523\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How specific isoform ratio alters vitreous ECM mechanically not established\", \"Tissue-to-tissue variability in isoform shift unexplained\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Positioned VCAN as a convergent downstream effector of multiple oncogenic and fibrotic programs—Snail/PAPSS2, TGF-β1/FAP, ERK5, STAT5—and showed ADAMTS1 cleavage of V1 generates EGFR-transactivating fragments driving invasion and anoikis resistance.\",\n      \"evidence\": \"shRNA/overexpression epistasis and rescue, CHIP/luciferase, RTK arrays, co-IP, migration/invasion/anoikis assays, conditional knockout and xenograft/fibrosis mouse models\",\n      \"pmids\": [\"29955124\", \"37461061\", \"41800245\", \"39333870\", \"40617369\", \"39554845\", \"39823128\", \"39578365\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PI3K/AKT placement downstream of VCAN largely inferred from inhibitor studies\", \"Some downstream pathways (CD44-Hippo-SP1, Twist1) rest on single-study Co-IP without orthogonal validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How specific VCAN isoforms and their proteolytic fragments are selectively generated and read out by distinct receptors to produce context-dependent developmental versus disease outcomes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model linking isoform/fragment identity to receptor choice\", \"Receptors for several functional activities (platelet, HNK-1-mediated migration, aggregate infiltration) remain unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 2, 16, 18]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [9, 13]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [9, 12, 14, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 1, 16, 19, 20]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [14, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 10, 16, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 7, 15, 20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [17, 21, 23, 24, 27, 28]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 13, 19, 27]}\n    ],\n    \"complexes\": [\n      \"versican-hyaluronan-link protein aggregate\",\n      \"G3-fibronectin-VEGF trimeric complex\"\n    ],\n    \"partners\": [\n      \"HAPLN1\",\n      \"FN1\",\n      \"VEGF\",\n      \"ITGB1\",\n      \"SELPLG\",\n      \"CD44\",\n      \"MDK\",\n      \"ADAMTS1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}